BD focalpoint slide profiler performance with atypical glandular cells on SurePath Papanicolaou smears
- PMID: 20209621
- DOI: 10.1002/cncy.20067
BD focalpoint slide profiler performance with atypical glandular cells on SurePath Papanicolaou smears
Abstract
Background: The FocalPoint Slide Profiler is an automated cervical cytology screening system that is approved for primary screening. It identifies up to 25% of slides as requiring No Further Review. However, few studies have evaluated FocalPoint performance with glandular abnormalities.
Methods: Sixty-six SurePath Papanicolaou (Pap) tests with a diagnosis of atypical glandular cells were identified. A total of 172 Pap tests with a diagnosis of "endometrial cells present" were included as controls. Follow-up histology was abnormal if diagnosed as high-grade squamous intraepithelial lesions, adenocarcinoma in situ, carcinoma, or complex endometrial hyperplasia. The FocalPoint software ranked each case into 1 of 7 categories: quintiles 1 (high risk) through 5 (low risk), No Further Review, and Process Review.
Results: A total of 215 slides were qualified for review; 38 (57.6%) atypical glandular cells cases were abnormal on follow-up biopsy, and 27 (71.1%) atypical glandular cells with abnormal follow-up qualified for review; no cases were classified No Further Review, and 9 (33%) were ranked in quintile 1. Twenty-three (82.1%) atypical glandular cells with benign follow-up were qualified for review; 3 (11%) cases were classified No Further Review, and 4 (17%) were ranked in quintile 1. There was a statistically significant difference between the ranking of benign atypical glandular cells cases, abnormal atypical glandular cells cases, and control cases (P = .03). However, when collapsed into No Further Review versus all other quintiles, the differences were not significant (P = .20).
Conclusions: The FocalPoint Slide Profiler did not classify glandular lesions with abnormal follow-up in the No Further Review category. However, these cases were not preferentially ranked in quintile 1. FocalPoint-screened slides need to be carefully reviewed for glandular abnormalities, regardless of the quintile ranking.
(c) 2010 American Cancer Society.
Comment in
-
Computer-assisted Papanicolaou imaging : another valuable tool in the challenge of Papanicolaou test screening for glandular neoplasia.Cancer Cytopathol. 2010 Apr 25;118(2):65-7. doi: 10.1002/cncy.20068. Cancer Cytopathol. 2010. PMID: 20336779 No abstract available.
Similar articles
-
Morphologic analysis of false negative SurePath® slides using Focalpoint™ GS computer-assisted cervical screening technology: An Australian experience.Diagn Cytopathol. 2015 Nov;43(11):870-8. doi: 10.1002/dc.23314. Epub 2015 Jul 15. Diagn Cytopathol. 2015. PMID: 26174002
-
Results of an Australian trial using SurePath liquid-based cervical cytology with FocalPoint computer-assisted screening technology.Diagn Cytopathol. 2012 Dec;40(12):1093-9. doi: 10.1002/dc.21848. Epub 2011 Nov 1. Diagn Cytopathol. 2012. PMID: 22045553
-
Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices.Acta Cytol. 2006 Jan-Feb;50(1):55-62. doi: 10.1159/000325895. Acta Cytol. 2006. PMID: 16514841
-
Clinical significance of atypical glandular cells on cervical cytology.Obstet Gynecol. 2006 Mar;107(3):701-8. doi: 10.1097/01.AOG.0000202401.29145.68. Obstet Gynecol. 2006. PMID: 16507944 Review.
-
Can glandular lesions be diagnosed in pap smear cytology?Diagn Cytopathol. 2000 Aug;23(2):127-33. doi: 10.1002/1097-0339(200008)23:2<127::aid-dc13>3.0.co;2-i. Diagn Cytopathol. 2000. PMID: 10888760 Review.
Cited by
-
USG Guided Fine Needle Aspiration Cytology along with Immunocytochemistry to Diagnose Primary Malignant Mixed Mullerian Tumors: A Three-Year Study from a Tertiary Care Center.J Cytol. 2022 Jan-Mar;39(1):9-13. doi: 10.4103/JOC.JOC_9_21. Epub 2022 Jan 21. J Cytol. 2022. PMID: 35341110 Free PMC article.
-
HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older: a prospective study.Int J Gynecol Cancer. 2020 Nov;30(11):1678-1683. doi: 10.1136/ijgc-2020-001457. Epub 2020 Oct 9. Int J Gynecol Cancer. 2020. PMID: 33037107 Free PMC article.
-
3cDe-Net: a cervical cancer cell detection network based on an improved backbone network and multiscale feature fusion.BMC Med Imaging. 2022 Jul 23;22(1):130. doi: 10.1186/s12880-022-00852-z. BMC Med Imaging. 2022. PMID: 35870877 Free PMC article.
-
[Computer-assisted diagnostics in cervical cytology].Pathologe. 2011 Nov;32(6):476-83. doi: 10.1007/s00292-011-1477-4. Pathologe. 2011. PMID: 22038134 Review. German.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials